Loading asset research
Nyxoah SA Ordinary Shares
NYXHNasdaq · USD · StocksQuote as of · Exchange session not verified$1.27
-4.51%
Today
NYXH
Loading 1D prices…
Market cap
$144.6M
Volume
183.8K
52w high
$6.8852w low
$1.26Company profile
Nyxoah SA Ordinary Shares
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
MONT-SAINT-GUIBERT, United States
Employees
153
Fiscal year end
1231
CIK
1857190
Session & valuation
Open$1.34
Previous close$1.27
Day high$1.47
Day low$1.34
30-day avg. volume415.2K
Outstanding shares43M
Diluted EPS-$2.36
Latest annual period
P/E (trailing)-0.54
P/E (forward)-1.70
Price / book1.47
Beta0.96
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3841
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KRMDKORU Medical Systems Inc. Common Stock (DE) | $144.5M | $41.1M | -6.41% | -$0.06 | -0.61% | Buy |
| LUCDLucid Diagnostics Inc. Common Stock | $159.9M | $4.7M | -1232.68% | -$0.43 | -1.67% | Buy |
| APYXApyx Medical Corporation Common Stock | $124.3M | $52.8M | -21.22% | -$0.27 | -0.00% | Buy |
| PYPDPolyPid Ltd. Ordinary Shares | $110.5M | $0.00 | — | $2.09 | +1.71% | Buy |
| PROFProfound Medical Corp. Common Stock | $214.1M | $16.1M | -264.44% | $1.41 | -2.35% | Buy |